Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NADIA: Dolutegravir vs Darunavir and Tenofovir vs Zidovudine in HIV Second-line Therapy
NCT03988452Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Jul 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dolutegravir and darunavir in human immunodeficiency virus infection (HIV), sponsored by Makerere University. Status: unknown.
02
Drugs
dolutegravirdarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03988452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03988452.